HIF-1α Dependent Upregulation of ZIP8, ZIP14, and TRPA1 Modify Intracellular Zn2+ Accumulation in Inflammatory Synoviocytes. 2021

Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
Laboratory of Cellular Pharmacology, School of Pharmacy, Aichi-Gakuin University, 1-100 Kusumoto, Chikusa, Nagoya 464-8650, Japan.

Intracellular free zinc ([Zn2+]i) is mobilized in neuronal and non-neuronal cells under physiological and/or pathophysiological conditions; therefore, [Zn2+]i is a component of cellular signal transduction in biological systems. Although several transporters and ion channels that carry Zn2+ have been identified, proteins that are involved in Zn2+ supply into cells and their expression are poorly understood, particularly under inflammatory conditions. Here, we show that the expression of Zn2+ transporters ZIP8 and ZIP14 is increased via the activation of hypoxia-induced factor 1α (HIF-1α) in inflammation, leading to [Zn2+]i accumulation, which intrinsically activates transient receptor potential ankyrin 1 (TRPA1) channel and elevates basal [Zn2+]i. In human fibroblast-like synoviocytes (FLSs), treatment with inflammatory mediators, such as tumor necrosis factor-α (TNF-α) and interleukin-1α (IL-1α), evoked TRPA1-dependent intrinsic Ca2+ oscillations. Assays with fluorescent Zn2+ indicators revealed that the basal [Zn2+]i concentration was significantly higher in TRPA1-expressing HEK cells and inflammatory FLSs. Moreover, TRPA1 activation induced an elevation of [Zn2+]i level in the presence of 1 μM Zn2+ in inflammatory FLSs. Among the 17 out of 24 known Zn2+ transporters, FLSs that were treated with TNF-α and IL-1α exhibited a higher expression of ZIP8 and ZIP14. Their expression levels were augmented by transfection with an active component of nuclear factor-κB P65 and HIF-1α expression vectors, and they could be abolished by pretreatment with the HIF-1α inhibitor echinomycin (Echi). The functional expression of ZIP8 and ZIP14 in HEK cells significantly increased the basal [Zn2+]i level. Taken together, Zn2+ carrier proteins, TRPA1, ZIP8, and ZIP14, induced under HIF-1α mediated inflammation can synergistically change [Zn2+]i in inflammatory FLSs.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070918 Synoviocytes Cells on the luminal surface of the SYNOVIAL MEMBRANE. Type A synoviocytes are MACROPHAGES responsible for waste removal from the joint cavity. Fibroblast-like type B synoviocytes are involved in production of joint matrix constituents (e.g., HYALURONAN; COLLAGEN; and FIBRONECTIN). Synoviocyte
D000074025 TRPA1 Cation Channel A highly conserved, non-selective TRP cation channel that contains 14-17 ANKYRIN REPEATS. It functions in cold sensation and NOCICEPTION of endogenous inflammatory factors and volatile irritants. TRPA1 is also activated by CANNABINOIDS and may play a role in sound perception by hair cells of the inner ear. TRPA1 Channel,Transient Receptor Potential Cation Channel Subfamily A, Member 1,Cation Channel, TRPA1,Channel, TRPA1,Channel, TRPA1 Cation
D015032 Zinc A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D042541 Intracellular Space The area within CELLS. Subcellular Space,Intracellular Spaces,Space, Intracellular,Space, Subcellular,Spaces, Intracellular,Spaces, Subcellular,Subcellular Spaces
D051795 Hypoxia-Inducible Factor 1, alpha Subunit Hypoxia-inducible factor 1, alpha subunit is a basic helix-loop-helix transcription factor that is regulated by OXYGEN availability and is targeted for degradation by VHL TUMOR SUPPRESSOR PROTEIN. Hypoxia Inducible Factor 1, alpha Subunit
D027682 Cation Transport Proteins Membrane proteins whose primary function is to facilitate the transport of positively charged molecules (cations) across a biological membrane. Cation Pumps,Cation Pump,Pump, Cation,Pumps, Cation

Related Publications

Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
August 2020, Brain sciences,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
May 2009, Proceedings of the National Academy of Sciences of the United States of America,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
December 2020, Free radical biology & medicine,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
August 2012, Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
August 2012, Annals of the rheumatic diseases,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
June 2013, Diabetologia,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
January 2014, PloS one,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
January 2016, Biological & pharmaceutical bulletin,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
December 2019, The Journal of biological chemistry,
Noriyuki Hatano, and Masaki Matsubara, and Hiroka Suzuki, and Yukiko Muraki, and Katsuhiko Muraki
April 2024, Disease models & mechanisms,
Copied contents to your clipboard!